IRIS
MONTIRONI, Rodolfo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.978
EU - Europa 21.478
AS - Asia 20.640
SA - Sud America 5.578
AF - Africa 936
Continente sconosciuto - Info sul continente non disponibili 763
OC - Oceania 22
AN - Antartide 1
Totale 96.396
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 46.188
SG - Singapore 6.506
BR - Brasile 4.395
VN - Vietnam 4.318
RU - Federazione Russa 3.945
UA - Ucraina 3.884
CN - Cina 2.533
IT - Italia 2.353
IE - Irlanda 2.240
HK - Hong Kong 2.225
DE - Germania 2.070
TR - Turchia 2.006
SE - Svezia 1.812
DK - Danimarca 1.440
FR - Francia 1.363
FI - Finlandia 979
KR - Corea 811
GB - Regno Unito 778
IN - India 459
BD - Bangladesh 424
AR - Argentina 409
CI - Costa d'Avorio 326
CA - Canada 298
MX - Messico 279
ID - Indonesia 214
EC - Ecuador 203
IQ - Iraq 193
ZA - Sudafrica 192
CO - Colombia 172
JP - Giappone 124
MA - Marocco 117
NL - Olanda 111
PK - Pakistan 110
VE - Venezuela 104
PL - Polonia 97
UZ - Uzbekistan 94
PH - Filippine 87
PY - Paraguay 85
ES - Italia 80
CL - Cile 72
SA - Arabia Saudita 66
BE - Belgio 58
EG - Egitto 56
EU - Europa 52
PE - Perù 52
TN - Tunisia 52
TH - Thailandia 49
JO - Giordania 48
UY - Uruguay 47
MY - Malesia 40
AT - Austria 39
KE - Kenya 38
DZ - Algeria 37
NP - Nepal 32
BO - Bolivia 31
CR - Costa Rica 30
HN - Honduras 30
KZ - Kazakistan 29
AE - Emirati Arabi Uniti 28
AZ - Azerbaigian 28
JM - Giamaica 28
RO - Romania 28
LB - Libano 25
DO - Repubblica Dominicana 24
EE - Estonia 24
ET - Etiopia 23
OM - Oman 23
IL - Israele 21
AL - Albania 20
KG - Kirghizistan 20
TW - Taiwan 20
PA - Panama 19
BH - Bahrain 18
GT - Guatemala 18
AU - Australia 17
PS - Palestinian Territory 17
TT - Trinidad e Tobago 16
BY - Bielorussia 14
CH - Svizzera 14
GR - Grecia 14
RS - Serbia 14
SN - Senegal 14
NG - Nigeria 13
AO - Angola 12
AM - Armenia 11
BG - Bulgaria 11
CZ - Repubblica Ceca 11
NI - Nicaragua 11
PT - Portogallo 11
LT - Lituania 10
SV - El Salvador 10
HU - Ungheria 9
KW - Kuwait 9
LV - Lettonia 9
LY - Libia 9
MD - Moldavia 9
SK - Slovacchia (Repubblica Slovacca) 8
SY - Repubblica araba siriana 8
GA - Gabon 7
GE - Georgia 7
Totale 95.544
Salva come PNG Salva come JPEG
Città #
Ashburn 7.121
Singapore 4.027
Jacksonville 3.949
Chandler 3.301
Fairfield 3.240
Dallas 2.299
Dublin 2.235
Hong Kong 2.159
Boardman 2.105
Des Moines 1.840
Wilmington 1.777
Woodbridge 1.434
Ho Chi Minh City 1.417
San Jose 1.368
Seattle 1.284
Houston 1.271
Cambridge 1.006
New York 984
Hanoi 971
The Dalles 946
Princeton 909
Lawrence 908
San Mateo 892
Lauterbourg 812
Council Bluffs 698
Moscow 604
Beijing 603
Ann Arbor 600
Milan 536
Hefei 466
San Diego 426
Centro 418
Los Angeles 417
São Paulo 365
Abidjan 326
Da Nang 220
Munich 202
Chicago 199
Haiphong 191
Santa Clara 185
Helsinki 184
Buffalo 179
London 179
Rio de Janeiro 143
Orem 133
Pune 133
Miano 129
Shanghai 118
Mexico City 109
Tokyo 100
Washington 100
Norwalk 96
Guangzhou 91
Tashkent 87
Belo Horizonte 86
Wuhan 86
Warsaw 85
Columbus 80
Johannesburg 79
Turku 79
Guayaquil 78
Curitiba 77
Brasília 76
Brooklyn 76
Redmond 75
Biên Hòa 74
Izmir 72
Montreal 71
Porto Alegre 71
Rome 70
Baghdad 67
Frankfurt am Main 67
Denver 66
Phoenix 63
Atlanta 62
Falls Church 62
Chennai 59
Hải Dương 58
Quito 56
Turin 56
Salvador 54
Vancouver 54
Can Tho 53
San Francisco 53
Brussels 52
Salt Lake City 52
Dhaka 51
Campinas 48
Marche 48
Kilburn 44
Thái Bình 44
Thái Nguyên 44
Amman 43
Elk Grove Village 43
Jakarta 43
Cape Town 41
Manchester 41
Boston 40
Santiago 40
Stockholm 39
Totale 59.270
Salva come PNG Salva come JPEG
Nome #
Urethral caruncle: clinicopathologic features of 41 cases 280
Metabolic phenotype of bladder cancer 265
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. 247
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. 232
Mitogen-activated protein kinases and apoptosis in PIN. 232
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis 229
Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). 229
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 217
Immunotherapy in genitourinary cancers: Where are we going? 210
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 206
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 203
Designing novel immunocombinations in metastatic renal cell carcinoma 203
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia 199
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 199
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 196
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 196
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 194
2004 WHO classification of the renal tumors of the adults. 192
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 191
Predicting future cancer burden in the United States by artificial neural networks 191
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 186
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 185
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in Renal Cell Carcinoma 182
Clinical performance and utility of a NNMT-based urine test for bladder cancer 181
D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness 179
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 179
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 178
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 175
[International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens]. 174
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation. 174
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 174
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 172
Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. 172
Exploring the Spectrum of Kidney Ciliopathies 171
The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors 171
Standardized mitotic counts in breast cancer evaluation of the method 169
Secondary neoplasms of the urinary system and male genital organs. 168
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 167
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 164
Role of DNA analysis and mutation of P53 gene in small dimension renal carcinomas. Biological significance and long-term follow-up 163
Primary B-cell lymphoblastic lymphoma of the testis 162
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 162
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 162
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 161
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 161
Green fluorescent protein as indicator of non-viral transient transfection efficiency in endometrial and testicular biopsies 160
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 160
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review. 159
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 159
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States 159
An update on investigational therapies that target STAT3 for the treatment of cancer 159
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 158
[Gene p53 mutation and prognosis in bladder tumors]. 158
[Thin glomerular basement membrane disease]. 158
[Interstitial cystitis: minimal diagnostic criteria]. 158
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 157
[Gleason's grading of prostatic cancer: a current perspective]. 157
Microbiome and cancers, with focus on genitourinary tumors 157
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 157
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 155
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 155
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 155
Metabolic Alterations in Renal and Prostate Cancer 154
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 154
[Adrenal metastasis: clinical and pathological aspects]. 153
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 152
Active surveillance for low-risk prostate cancer. 151
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises 150
Succinate dehydrogenase-deficient renal cell carcinoma: Detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma 149
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 148
[The kidney in rheumatoid arthritis]. 148
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications 148
Molecular characterization of testicular germ cell tumors using tissue microdissection 147
Bone targeting agents in patients with metastatic prostate cancer: State of the art 147
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 147
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 146
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 146
Diagnostic Criteria for Ductal Adenocarcinoma of the Prostate.Interobserver Variability among 20 Expert Uropathologists. 146
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 146
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 145
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 145
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 145
Is There a Role for Immunotherapy in Prostate Cancer? 145
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 144
Genitourinary cancers: molecular determinants for personalized therapies 143
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume 143
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 142
2009 update on the classification of renal epithelial tumors in adults 142
[Prostate biopsy: characteristics of the histological sample]. 142
[Quantitative microscopy in histopathology]. 141
2005 update on pathology of prostate biopsies with cancer 141
A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium. 141
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 141
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 141
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 140
AR-V7 and prostate cancer: The watershed for treatment selection? 140
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 140
Pd-l1 inhibitors for the treatment of prostate cancer 140
The 1996 European Urology Focus on Preneoplastic Lesions of the Prostate 140
Totale 16.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 468.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 468.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.014 0 1.544 134 320 93 550 203 433 471 538 384 1.344
2022/202311.106 1.117 781 605 970 808 2.574 11 656 2.831 51 421 281
2023/20246.103 1.234 164 343 996 1.048 1.157 112 111 20 94 56 768
2024/202512.595 1.094 1.127 630 341 398 468 1.047 556 3.732 937 957 1.308
2025/202632.743 1.469 2.441 2.552 3.702 2.669 2.157 5.810 3.643 3.196 2.815 655 1.634
2026/20271.916 1.564 352 0 0 0 0 0 0 0 0 0 0
Totale 96.396